Meeting
2020 Genitourinary Cancers Symposium
The risk of death from prostate cancer in men with Gleason Score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.
Authors
David Dewei Yang
Harvard Radiation Oncology Program, Boston, MA
David Dewei Yang , Ming-Hui Chen , Michelle H. Braccioforte , Brian Joseph Moran , Anthony Victor D'Amico
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 330)
Abstract #
330
Poster Bd #
M14
Abstract Disclosures
Similar Posters
Poster
2011 Genitourinary Cancers Symposium
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease.
First Author: Nils Arvold
Poster
2019 ASCO Annual Meeting
Cardiorespiratory fitness and cardiovascular mortality after prolonged androgen deprivation therapy for prostate cancer.
First Author: Jingyi Gong
Poster
2019 Genitourinary Cancers Symposium
The effect of the timing of biochemical failure after external beam radiotherapy or low-dose-rate brachytherapy for definitive prostate cancer treatment.
First Author: Jay P. Ciezki
Poster
2018 Genitourinary Cancers Symposium
Early versus delayed initiation of salvage androgen deprivation therapy and the risk of prostate cancer-specific mortality.
First Author: Brandon Arvin Virgil Mahal